Feb 8, 2023 05:00PM

Feb 6, 2023 05:00PM

Feb 1, 2023 05:00PM

Jan 31, 2023 05:00PM

Jan 12, 2023 07:30AM

Nov 8, 2022 05:30PM

Nov 2, 2022 08:00AM Medexus Schedules Second Quarter 2023 Conference Call

Oct 6, 2022 07:30AM

Sep 29, 2022 05:05PM

Sep 19, 2022 08:00AM

Sep 15, 2022 05:05PM

Aug 8, 2022 05:00PM

Aug 2, 2022 05:00PM

Jul 25, 2022 07:00AM Treosulfan NDA Resubmitted to FDA

Jun 22, 2022 05:50PM

Jun 14, 2022 04:30PM

Jun 6, 2022 08:30AM

May 24, 2022 05:05PM

Apr 22, 2022 08:30AM

Apr 19, 2022 04:20PM

Mar 9, 2022 08:00AM Medexus to Participate in the 34th Annual Roth Conference

Mar 1, 2022 07:15AM

Feb 14, 2022 08:00AM

Feb 9, 2022 06:30PM

Feb 1, 2022 04:15PM

Jan 31, 2022 08:00AM

Dec 2, 2021 08:08AM

Nov 10, 2021 05:00PM Medexus Pharmaceuticals Reports Financial and Operational Results for the Three- and Six-Month Periods Ending September 30, 2021

Nov 1, 2021 09:27AM

Sep 21, 2021 06:09PM

Aug 16, 2021 05:30PM

Aug 12, 2021 07:30AM

Aug 4, 2021 10:58AM

Aug 3, 2021 07:45AM

Jul 12, 2021 09:29AM Medexus Pharmaceuticals and medac GmbH enter into Licensing Agreement for First-in-Class Conditioning Agent, Treosulfan, in Canada

Jun 28, 2021 04:30PM

Jun 16, 2021 05:00PM

Jun 10, 2021 08:30AM

Jun 9, 2021 08:30AM

Mar 1, 2021 05:00PM

Feb 2, 2021 02:21PM

Dec 21, 2020 09:52AM Medexus (MDP.V) expands specialty pharmaceuticals portfolio

Dec 18, 2020 08:30AM

Nov 16, 2020 08:00AM

Jun 22, 2020 05:15PM

Feb 28, 2020 08:59AM

Oct 15, 2019 08:37PM

Oct 9, 2019 08:00AM

Oct 2, 2019 09:07PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sarepta Therapeutics, Canada Goose, Meredith Corporation, and MacroGenics and Encourages Investors to C

Sep 18, 2019 08:01PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All